The Contribution of Genetic Modifiers to Ovarian Cancer Risk in &lt;i&gt;BRCA1&lt;/i&gt; and &lt;i&gt;BRCA2&lt;/i&gt; Pathogenic Variant Carriers. This evidence concerns the gene BRCA2 and ovarian carcinoma.